Managing And Reducing Costs For Heart Failure Via Home Monitoring
Main Category: Heart DiseaseAlso Included In: Caregivers / Homecare; IT / Internet / E-mail
Article Date: 05 Jan 2012 - 0:00 PST
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
2 (1 votes) |
Heart failure affects 5.8 million people in the U.S. alone and is responsible for nearly 1 million hospitalizations each year, most resulting from a build-up of body fluid in the lungs and other organs due to the heart's inability to pump effectively. The disease needs to be closely tracked in order to avoid such hospitalizations, and home-monitoring interventions may be especially useful, UCLA researchers say.
In their new paper, the UCLA authors discuss the importance of heart failure disease-management and early identification, as well as the treatment of body-fluid congestion, using a number of home-monitoring strategies, including self-care, such as daily weighing and medication management; phone calls from a nurse or automated response system; home health visits; and telemedicine and remote monitoring with implantable and external devices to track vital information.
Impact: The field of heart failure home-monitoring is fairly new. Further study will help assess optimal approaches, such as identifying which patients may benefit the most from such monitoring, and will determine which health data - blood pressure or shortness of breath, for example - may be the best to monitor. Promising new technologies, including devices to track heart-ventricle and pulmonary artery pressures, which are closely related to congestion development and clinical outcomes, may be particularly promising.
The authors suggest that the best approach is most likely multi-pronged, including monitoring along with patient follow-up and feedback.
Visit our heart disease section for the latest news on this subject.
AUTHORS: Dr. Gregg C. Fonarow, UCLA's Eliot Corday Professor of Cardiovascular Medicine and Science, director of the Ahmanson-UCLA Cardiomyopathy Center, and co-chief of clinical cardiology at the David Geffen School of Medicine at UCLA.
FUNDING: The Ahmanson Foundation and the Agency for Healthcare Research and Quality funded the research. Fonarow has served as a consultant for Medtronic.
JOURNAL: The research appears in the Jan. 10 issue of the Journal of the American College of Cardiology.
University of California - Los Angeles Health Sciences
MLA
23 Feb. 2012. <http://www.medicalnewstoday.com/releases/239902.php>
APA
http://www.medicalnewstoday.com/releases/239902.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





